Supplement tables and figures for Associations between life-course body shape and sex hormone concentrations in men, pre- and postmenopausal women

Supplemental Table 1. Trajectory modelling and model fit characteristics in men (HPFS), postmenopausal women (NHS+ NHS II) and premenopausal women (NHS+ NHS II). Supplemental Table 2. Sensitivity analysis on women who have never been exposed to hormone therapy. Percentage difference in biomarker levels between the reference group (the medium-stable group in postmenopausal women and the lean-stable/moderate group in premenopausal women) and the other trajectory groups in postmenopausal (NHS+ NHS II) and premenopausal women (NHS+ NHS II) Supplement Figure1. Flowchart of study participants. a) Of 3053 eligible men in the HPFS, 2431 were included in the final study. b) Of 7860 eligible women in the NHS study and 4517 in the NHS 2, 4801 premenopausal and 6018 postmenopausal women were included in the final study.补充表1 男性（健康专业人员随访研究，HPFS）、绝经后女性（护士健康研究与护士健康研究II，NHS+ NHS II）及绝经前女性（护士健康研究与护士健康研究II，NHS+ NHS II）的轨迹建模与模型拟合特征。 补充表2 针对从未接触过激素治疗女性的敏感性分析：对比绝经后女性（护士健康研究与护士健康研究II，NHS+ NHS II）与绝经前女性（护士健康研究与护士健康研究II，NHS+ NHS II）中，参照组（绝经后女性的中等稳定组、绝经前女性的偏瘦稳定/中等组）与其余轨迹组的生物标志物水平百分比差值。 补充图1 研究参与者流程图。a) 健康专业人员随访研究（HPFS）的3053名符合纳入标准的男性中，最终有2431名被纳入本研究。b) 护士健康研究（NHS）的7860名符合纳入标准的女性与护士健康研究II（NHS II）的4517名符合纳入标准的女性中，最终纳入4801名绝经前女性与6018名绝经后女性。